InvestorsHub Logo
Followers 14
Posts 730
Boards Moderated 0
Alias Born 03/14/2010

Re: eightisenough post# 261080

Friday, 04/03/2020 8:17:30 AM

Friday, April 03, 2020 8:17:30 AM

Post# of 425263
Eight. Appreciate your posts. Crux of case to me is how Judge Du dismisses the unexpected benefit of Apo B. This secondary consideration (in addition to the unmet need) was the major reason we were granted the patent. In Judge Du decision, we were only favored on unmet need and commercial praise. I think another secondary consideration would have been key and/or the original one of unexpected benefit. Do you have access to the original patent comments. I’d love to know what the patent examiner said about Apo B back then.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News